Evidence 1
Activity
Activity
Survival rate
Survival rate = 47% at 32 µg/ml
Anticancer
Target
Blood Cancer
Jurkat
Blood
Assay & Model
MTT assay
24-h
Source & Reference
dbAMP 3.0
CancerPPD 2.0
CancerPPD2
2023
Other
| Source Activity Label | Source Definition |
|---|---|
| Anticancer |
CancerPPD 2.0
manually curated experimentally verified anticancer peptide/protein annotation.
dbAMP 3.0
classified as Anticancer under the disease-associated peptide function classes.
|